If you need more lookups,
subscriptions start at $34 USD/month.
Victor Chen Location
Shanghai, China
Victor Chen Work
2019 -now Head of Early Development @
2016 -2019 Site Head, Pharmaceutical R and D Early Development @ Covance China and Asia Pacific
2011 -2016 Senior Research Fellow @
2009 -2011 Associate Director @ Ablynx (acquired and wholly-owned subsidiary by Sanofi)
2005 -2009 Director @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
2001 -2005 Sr Principal Scientist @
1999 -2001 Sr. Research Scientist @
Victor Chen Education
National Institutes of Health (NIH)
Post-Doctoral Fellow
1994-1996
University of California
Doctor of Philosophy - PhD
1989-1994
Victor Chen Skills
Biotechnology
Life Sciences
Drug Discovery
Pharmaceutical Industry
CRO Management
Drug Development
Oncology
Good Laboratory Practice (GLP)
Toxicology
Clinical Development
Immunology
Biologics
Small Molecules
Management
Project Management
Good Laboratory Practice Glp
Safety Pharmacology
Science
Team Leadership
Good Laboratory Practice
Victor Chen Summary
Victor Chen, based in Shanghai, China, is currently a Head of Early Development at HARBOUR BIOMED. Victor Chen brings experience from previous roles at Covance China and Asia Pacific, Boehringer Ingelheim, Ablynx (acquired and wholly-owned subsidiary by Sanofi) and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Victor Chen holds a 1994 - 1996 Post-Doctoral Fellow @ National Institutes of Health (NIH). With a robust skill set that includes Biotechnology, Life Sciences, Drug Discovery, Pharmaceutical Industry, CRO Management and more. Victor Chen has 2 emails on RocketReach.
Looking for a different Victor Chen?
Find contact details for 700 million professionals.